Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis

(2018) Divyanshu Dubey et al.   ANNALS OF NEUROLOGY

Antibody-Mediated Encephalitis

(2018) Josep Dalmau et al.   NEW ENGLAND JOURNAL OF MEDICINE

Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis

(2017) Olafur Sveinsson et al.   JOURNAL OF NEUROIMMUNOLOGY

Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System

(2017) Josep Dalmau et al.   PHYSIOLOGICAL REVIEWS

Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study

(2016) Josephine Heine et al.   JOURNAL OF NEUROLOGY

A clinical approach to diagnosis of autoimmune encephalitis

(2016) Francesc Graus et al.   LANCET NEUROLOGY

Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis

(2016) Franziska Scheibe et al.   NEUROLOGY

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

(2015) Tobias Alexander et al.   ANNALS OF THE RHEUMATIC DISEASES

Refractory Primary Sjögren Syndrome Successfully Treated With Bortezomib

(2015) Juan Jakez-Ocampo et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

(2013) An-Wen Chan et al.   ANNALS OF INTERNAL MEDICINE

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

(2013) Maarten J Titulaer et al.   LANCET NEUROLOGY

Pathogenic Long-Lived Plasma Cells and Their Survival Niches in Autoimmunity, Malignancy, and Allergy

(2012) O. Winter et al.   JOURNAL OF IMMUNOLOGY

Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis

(2011) E. Martinez-Hernandez et al.   NEUROLOGY

N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

(2010) Sarosh R. Irani et al.   BRAIN

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

(2010) Josep Dalmau et al.   LANCET NEUROLOGY

Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin

(2010) H. Pruss et al.   NEUROLOGY

A guide to the design and analysis of small clinical studies

(2010) Farid Kianifard et al.   PHARMACEUTICAL STATISTICS

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE